PEP braces for a Q2 earnings drop as North America softness, inflation and global cost pressures weigh on margins.

The jury is out on whether junk food is addictive, but there is clear evidence that a diet high in ultra-processed fare is linked to several diseases.

PEP stock slides to a 52-week low as weak North America sales and cautious 2025 guidance weigh on investor sentiment.